But I think the Pharma companies are getting more savy, and they recognize that consumers are more capable of shopping around accross borders, so that this time, the
price that is set
in US may not be too different from the
price elsewhere. US is the big money market, so I suspect big pharma would sooner not sell to the UK government, or another government, than see that sale damage the price they can obtain from the insurance route in the US.